Clinical Trials Browser

Interventional × Neuroendocrine Tumors × Lenalidomide × Clear all

NCT01218555 2022-01-27

Study of Everolimus (RAD001) in Combination With Lenalidomide

Phase 1 Completed

44 enrolled 9 charts

EndocrineGenitourinaryNET

Kidney Neoplasms, Neuroendocrine Tumors